Skip to main content

Table 2 Types of severe adverse effects registered in DRC after ivermectin treatment, between 2003 and 2017

From: Analysis of severe adverse effects following community-based ivermectin treatment in the Democratic Republic of Congo

Types of severe adverse effects N (%)
Non-neurological SAE (N = 314)  
 Asthenia 65 (20.7)
 Vertigos 20 (6.4)
 Itching 15 (4.8)
 Localised or generalised oedema 9 (2.9)
 Severe headache 235 (74.8)
 Myalgia 201 (64.0)
 Diarrhoea + vomiting 88 (28.0)
 Arthralgia 197 (62.7)
Neurological SAE (N = 631)
 Coma 594 (94.1)
 Paralysis 13 (2.1)
 Palpebral SCH 245 (38.8)
 Speech disabilities 188 (29.8)
 Motor deficit 476 (75.4)
  1. SAE = severe adverse effects, N = number, SCH = subconjunctival haemorrhage